<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Crispr on NV Trends</title><link>https://blogs.nvtrends.com/tags/crispr/</link><description>Recent content in Crispr on NV Trends</description><generator>Hugo</generator><language>en-us</language><lastBuildDate>Sat, 13 Jun 2026 02:31:51 +0000</lastBuildDate><atom:link href="https://blogs.nvtrends.com/tags/crispr/index.xml" rel="self" type="application/rss+xml"/><item><title>CRISPR Breakthrough: Shredding Undruggable Cancers</title><link>https://blogs.nvtrends.com/posts/2026/crispr-cas12a2-shredding-cancer-breakthrough/</link><pubDate>Sat, 13 Jun 2026 02:31:51 +0000</pubDate><guid>https://blogs.nvtrends.com/posts/2026/crispr-cas12a2-shredding-cancer-breakthrough/</guid><description>&lt;p&gt;For decades, the word &amp;ldquo;cancer&amp;rdquo; has been met with a mixture of fear and resilience in Indian households. Despite massive leaps in medical science, from advanced chemotherapy to targeted immunotherapy, some forms of the disease have remained stubbornly &amp;ldquo;undruggable.&amp;rdquo; These are the cancers that don&amp;rsquo;t just survive our best treatments—they thrive, often because they lack the specific &amp;ldquo;handles&amp;rdquo; that traditional drugs need to grab onto. For a family in Mumbai or Delhi, a diagnosis of pancreatic or late-stage lung cancer often feels like an insurmountable wall, both medically and financially.&lt;/p&gt;</description></item></channel></rss>